(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOCRYST

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BIOCRYST

ST13

US500000077254497

Class

42

Filing

77254497

Registration

3974837

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

63

Latest update

01/13/2026

Trademark type

Word

Nice classes

42

Filing date

08/14/2007

Registration date

06/07/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/04/2022

Last transaction

01/13/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/14/2007

First use in commerce

08/14/2007

Drawing code

4

Owner type

03

Owner location

Durham, NC

Examiner

CHOE,KELLY

Law office

M40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.

Representatives

Erica L. Han Ropes & Gray LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceutical research and drug development; medical and scientific researchconducting clinical trials; development of pharmaceuticals for the treatment of infectiousviralinflammatoryimmunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of inflammatory connective tissue diseases; development of pharmaceuticals for the treatment of influenza and hepatitis ; development of pharmaceuticals for the treatment of cancercancers of the immune system such as T-cell and B-cell leukemias and lymphoma

Publications

History of USPTO decisions and trademark events.

63 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/03/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/02/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/03/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/04/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/04/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/04/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/04/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

12/06/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/21/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/21/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/21/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/06/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/06/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/06/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/16/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/16/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/16/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/16/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/16/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

06/07/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/12/2018

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/01/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/01/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/31/2017

E815

TEAS SECTION 8 & 15 RECEIVED

06/15/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

06/07/2011

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/04/2011

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

05/03/2011

ALIE

ASSIGNED TO LIE

04/30/2011

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/14/2011

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/25/2011

IUAF

USE AMENDMENT FILED

03/23/2011

EISU

TEAS STATEMENT OF USE RECEIVED

03/23/2011

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/28/2010

EX5G

SOU EXTENSION 5 GRANTED

09/27/2010

EXT5

SOU EXTENSION 5 FILED

09/22/2010

EEXT

SOU TEAS EXTENSION RECEIVED

09/22/2010

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/31/2010

EX4G

SOU EXTENSION 4 GRANTED

03/30/2010

EXT4

SOU EXTENSION 4 FILED

03/25/2010

EEXT

SOU TEAS EXTENSION RECEIVED

03/25/2010

EX3G

SOU EXTENSION 3 GRANTED

09/29/2009

EXT3

SOU EXTENSION 3 FILED

09/24/2009

EEXT

SOU TEAS EXTENSION RECEIVED

09/24/2009

EX2G

SOU EXTENSION 2 GRANTED

04/08/2009

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/08/2009

EXT2

SOU EXTENSION 2 FILED

03/24/2009

EEXT

SOU TEAS EXTENSION RECEIVED

03/24/2009

EX1G

SOU EXTENSION 1 GRANTED

09/25/2008

EXT1

SOU EXTENSION 1 FILED

09/25/2008

EEXT

SOU TEAS EXTENSION RECEIVED

09/25/2008

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

03/25/2008

PUBO

PUBLISHED FOR OPPOSITION

01/01/2008

NPUB

NOTICE OF PUBLICATION

12/12/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/28/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/23/2007

XAEC

EXAMINER'S AMENDMENT ENTERED

11/23/2007

ALIE

ASSIGNED TO LIE

11/23/2007

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/23/2007

GNEA

EXAMINERS AMENDMENT E-MAILED

11/23/2007

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/23/2007

DOCK

ASSIGNED TO EXAMINER

11/21/2007

NWAP

NEW APPLICATION ENTERED

08/17/2007

Continuous trademark protection

Get notified about every new filing that threatens BIOCRYST or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.